Designtx
3 known investors
Design Therapeutics is a biopharmaceutical company developing small molecule therapeutic candidates for serious genetic diseases through its GeneTAC (Gene Targeted Chimera) platform. Its pipeline focuses on monogenic repeat expansion disorders such as Friedreich ataxia, Fuchs endothelial corneal dystrophy, myotonic dystrophy, and Huntington's disease.
Investors · 3
Frequently asked questions
- What does Designtx do?
- Design Therapeutics is a biopharmaceutical company developing small molecule therapeutic candidates for serious genetic diseases through its GeneTAC (Gene Targeted Chimera) platform. Its pipeline focuses on monogenic repeat expansion disorders such as Friedreich ataxia, Fuchs endothelial corneal dystrophy, myotonic dystrophy, and Huntington's disease.
- Who are Designtx's investors?
- Designtx's investors include Avoro Capital Advisors, Quan Capital, WestRiver Group.